Sveriges mest populära poddar

IFN-λ therapy for GvHD, mechanism of decitabine in ITP, and TET2 mutations in chronic NK-LGL leukemia

18 min•26 augusti 2021

In this week's episode, we will review a study that proposes IFN-λ therapy as a novel strategy to boost gut protection in GvHD, examine the immunomodulatory effects of decitabine in ITP, and learn about the discovery of TET2 mutations in chronic natural killer large granular lymphocyte leukemia

Fler avsnitt av Blood Podcast

Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

13 aug.•33 min

HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAIT

6 aug.•17 min

FLT3-ITD microclones in AML and Results from the RESET-PV trial

30 juli•14 min

Initial CHORUS data on HHT and ASH HematOmics Program

23 juli•26 min

IV Iron during Acute Infection and Revisiting iTTP Refractoriness

16 juli•17 min

A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies

9 juli•18 min

IV Iron Risks and Low-Dose AML Gains

2 juli•25 min

Orca-T for GVHD–free survival and Understanding VEXAS anemia

25 juni•23 min

Treating AML, Before and After Relapse

18 juni•16 min

Future Directions in Relapsed and Refractory Large B-cell Lymphoma

11 juni•25 min

Blood Podcast med American Society of Hematology finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.